Fast Five Quiz: How Much Do You Know About Metastatic Bone Disease?

Maurie Markman, MD


May 20, 2019

In a study of 462 patients presenting with metastatic bone disease to the extremities or pelvis and undergoing orthopedic treatment, only preoperative hemoglobin was found to be an independent predictor of increased survival. Conversely, lung histotype, age, pathologic fracture, and previous combined therapy were all negative predictors of survival. It has also been observed that life expectancy tends to be longer for patients with a primary breast or prostate carcinoma than for those with lung carcinoma. Patients with renal cell or thyroid carcinoma have a variable life expectancy.

Learn more about prognostic factors here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.